PMEF
USNA icon

Point72 Middle East FZE’s Usana Health Sciences USNA Stock Holding History

Point72 Middle East FZE’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-313
Closed -$18.4K – 1906
2023
Q3 		$18.4K Sell
313
-2,253
-88% -$141K ﹤0.01% 1319
2023
Q2 		$162K Buy
+2,566
New +$163K ﹤0.01% 1117

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Point72 Middle East FZE's USNA Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Usana Health Sciences (USNA) in Q4 2023, closing a stake of 313 shares — an estimated $18.4K sold.

Point72 Middle East FZE first reported a position in USNA in Q2 2023 and held it in 2 quarters. The position peaked at $162K in Q2 2023. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Usana Health Sciences position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 313 Usana Health Sciences shares in Q4 2023, an estimated $18.4K.
  • Point72 Middle East FZE first reported a position in Usana Health Sciences in Q2 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Usana Health Sciences position peaked at $162K in Q2 2023.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.